Wisp launches weight care vertical for women with hormonal imbalances
Wisp, a women's telehealth company offering sexual and reproductive health solutions, announced the introduction of its weight care vertical.
The company will provide women with personalized, online healthcare consultations, offering four products, including GLP-1s, to help women struggling with hormonal imbalances due to conditions like perimenopause and menopause, Polycystic Ovary Syndrome and endometriosis. With this launch, the company debuts its first-ever exclusive over-the-counter weight care capsules.
“Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet overlooked aspect of women’s health,” said Monica Cepak, CEO of Wisp. “As the dialogue around obesity evolves, we recognize that underlying conditions — especially hormonal imbalances linked to perimenopause and menopause — remain under-researched, underdiagnosed and undertreated. With these new offerings, we’re proud to continue expanding access to comprehensive care, offering tailored solutions for every woman and every condition at every price point.”
[Read more: SoWell debuts supplement system for GLP-1 users]
Patients can request prescription GLP-1 medications and OTC supplements via pharmacy pickup or free discreet delivery. The process starts with a digital health consultation on Wisp’s platform, which a licensed medical provider then reviews, and if deemed safe and suitable, patients can begin the program.
In addition to educational content and monthly check-ins, Wisp’s weight care program includes the following options:
- Semaglutide (Branded FDA-Approved Wegovy) Subcutaneous Injectable Medication
- Compounded Semaglutide Subcutaneous Injectable Medication
- Compounded Sublingual Semaglutide
- Metabolic Support & GLP-1 Boost Capsules
[Read more: Ozempic Conundrum: Holy grail or Pandora’s box?]
The company also shared that it is expanding its menopause solutions with offerings tailored to support the more than 2 million women who experience menopause each year. Seeing the potential to improve treatments and access, Wisp is enhancing its perimenopause and menopause offerings with new prescription Estriol Face Cream as well as new hormone replacement therapy treatments: Transdermal Estradiol Patches, Oral Micronized Progesterone Capsules and Oral Provera Tablets.
Wisp’s move into weight management is part of its broader vision to support women at every stage of life. The brand plans to broaden its strategic partnerships and deepen its footprint, expanding its offerings to more at-home diagnostics and treatment options later this year across STI, fertility, menopause and weight care categories.